Industrial - Machinery
Compare Stocks
5 / 10Stock Comparison
IR vs ROP vs VRSK vs IEX vs MSCI
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
Consulting Services
Industrial - Machinery
Financial - Data & Stock Exchanges
IR vs ROP vs VRSK vs IEX vs MSCI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Industrial - Machinery | Industrial - Machinery | Consulting Services | Industrial - Machinery | Financial - Data & Stock Exchanges |
| Market Cap | $30.35B | $36.28B | $22.89B | $15.97B | $42.83B |
| Revenue (TTM) | $7.78B | $8.12B | $3.10B | $3.53B | $3.13B |
| Net Income (TTM) | $587M | $1.71B | $910M | $508M | $1.32B |
| Gross Margin | 38.2% | 69.4% | 67.4% | 44.4% | 82.4% |
| Operating Margin | 18.1% | 28.1% | 44.9% | 20.8% | 54.7% |
| Forward P/E | 22.0x | 16.1x | 22.9x | 25.5x | 30.0x |
| Total Debt | $4.78B | $9.30B | $5.04B | $1.82B | $6.31B |
| Cash & Equiv. | $1.25B | $297M | $2.18B | $580M | $515M |
IR vs ROP vs VRSK vs IEX vs MSCI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Ingersoll Rand Inc. (IR) | 100 | 274.8 | +174.8% |
| Roper Technologies,… (ROP) | 100 | 89.5 | -10.5% |
| Verisk Analytics, I… (VRSK) | 100 | 101.2 | +1.2% |
| IDEX Corporation (IEX) | 100 | 134.8 | +34.8% |
| MSCI Inc. (MSCI) | 100 | 178.9 | +78.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IR vs ROP vs VRSK vs IEX vs MSCI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IR lags the leaders in this set but could rank higher in a more targeted comparison.
ROP carries the broadest edge in this set and is the clearest fit for growth exposure and valuation efficiency.
- Rev growth 12.3%, EPS growth -1.0%, 3Y rev CAGR 13.7%
- PEG 1.68 vs IEX's 4.77
- 12.3% revenue growth vs IR's 5.7%
- Lower P/E (16.1x vs 30.0x), PEG 1.68 vs 1.77
Among these 5 stocks, VRSK doesn't own a clear edge in any measured category.
IEX is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 23 yrs, beta 0.95, yield 1.3%
- Lower volatility, beta 0.95, Low D/E 45.2%, current ratio 2.86x
- Beta 0.95, yield 1.3%, current ratio 2.86x
- 1.3% yield, 23-year raise streak, vs MSCI's 1.2%
MSCI ranks third and is worth considering specifically for long-term compounding.
- 7.2% 10Y total return vs IR's 299.5%
- 38.4% margin vs IR's 7.5%
- 24.0% ROA vs IR's 3.2%, ROIC 34.9% vs 7.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.3% revenue growth vs IR's 5.7% | |
| Value | Lower P/E (16.1x vs 30.0x), PEG 1.68 vs 1.77 | |
| Quality / Margins | 38.4% margin vs IR's 7.5% | |
| Stability / Safety | Beta 0.43 vs IR's 1.48, lower leverage | |
| Dividends | 1.3% yield, 23-year raise streak, vs MSCI's 1.2% | |
| Momentum (1Y) | +20.9% vs VRSK's -43.0% | |
| Efficiency (ROA) | 24.0% ROA vs IR's 3.2%, ROIC 34.9% vs 7.8% |
IR vs ROP vs VRSK vs IEX vs MSCI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
IR vs ROP vs VRSK vs IEX vs MSCI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MSCI leads in 1 of 6 categories
ROP leads 1 • IR leads 1 • IEX leads 1 • VRSK leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MSCI leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ROP is the larger business by revenue, generating $8.1B annually — 2.6x VRSK's $3.1B. MSCI is the more profitable business, keeping 38.4% of every revenue dollar as net income compared to IR's 7.5%. On growth, ROP holds the edge at +11.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $7.8B | $8.1B | $3.1B | $3.5B | $3.1B |
| EBITDAEarnings before interest/tax | $1.9B | $3.2B | $1.7B | $945M | $2.0B |
| Net IncomeAfter-tax profit | $587M | $1.7B | $910M | $508M | $1.3B |
| Free Cash FlowCash after capex | $1.2B | $2.6B | $1.1B | $611M | $1.5B |
| Gross MarginGross profit ÷ Revenue | +38.2% | +69.4% | +67.4% | +44.4% | +82.4% |
| Operating MarginEBIT ÷ Revenue | +18.1% | +28.1% | +44.9% | +20.8% | +54.7% |
| Net MarginNet income ÷ Revenue | +7.5% | +21.1% | +29.3% | +14.4% | +38.4% |
| FCF MarginFCF ÷ Revenue | +14.9% | +31.4% | +36.3% | +17.3% | +49.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.6% | +11.3% | +3.9% | +8.9% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +6.5% | +59.1% | +4.8% | +27.8% | +49.1% |
Valuation Metrics
ROP leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 24.8x trailing earnings, ROP trades at a 54% valuation discount to IR's 53.4x P/E. Adjusting for growth (PEG ratio), MSCI offers better value at 2.23x vs IEX's 6.27x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $30.4B | $36.3B | $22.9B | $16.0B | $42.8B |
| Enterprise ValueMkt cap + debt − cash | $33.9B | $45.3B | $25.7B | $17.2B | $48.6B |
| Trailing P/EPrice ÷ TTM EPS | 53.45x | 24.82x | 26.92x | 33.51x | 37.81x |
| Forward P/EPrice ÷ next-FY EPS est. | 22.05x | 16.08x | 22.85x | 25.52x | 29.99x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.59x | 3.16x | 6.27x | 2.23x |
| EV / EBITDAEnterprise value multiple | 17.61x | 14.57x | 15.34x | 18.58x | 25.17x |
| Price / SalesMarket cap ÷ Revenue | 3.97x | 4.59x | 7.45x | 4.62x | 13.67x |
| Price / BookPrice ÷ Book value/share | 3.06x | 1.91x | 78.44x | 4.02x | — |
| Price / FCFMarket cap ÷ FCF | 24.88x | 14.55x | 19.20x | 25.89x | 27.65x |
Profitability & Efficiency
Evenly matched — IEX and MSCI each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
VRSK delivers a 4.4% return on equity — every $100 of shareholder capital generates $4 in annual profit, vs $6 for IR. IEX carries lower financial leverage with a 0.45x debt-to-equity ratio, signaling a more conservative balance sheet compared to VRSK's 16.26x. On the Piotroski fundamental quality scale (0–9), MSCI scores 8/9 vs VRSK's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +5.8% | +8.8% | +4.4% | +12.6% | — |
| ROA (TTM)Return on assets | +3.2% | +5.0% | +16.7% | +7.3% | +24.0% |
| ROICReturn on invested capital | +7.8% | +6.1% | +33.0% | +10.4% | +34.9% |
| ROCEReturn on capital employed | +8.7% | +7.7% | +39.6% | +11.6% | +44.3% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 | 5 | 7 | 8 |
| Debt / EquityFinancial leverage | 0.47x | 0.47x | 16.26x | 0.45x | — |
| Net DebtTotal debt minus cash | $3.5B | $9.0B | $2.9B | $1.2B | $5.8B |
| Cash & Equiv.Liquid assets | $1.2B | $297M | $2.2B | $580M | $515M |
| Total DebtShort + long-term debt | $4.8B | $9.3B | $5.0B | $1.8B | $6.3B |
| Interest CoverageEBIT ÷ Interest expense | 4.53x | 6.50x | 7.87x | 11.33x | 7.67x |
Total Returns (Dividends Reinvested)
IR leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in IR five years ago would be worth $15,409 today (with dividends reinvested), compared to $8,255 for ROP. Over the past 12 months, IEX leads with a +20.9% total return vs VRSK's -43.0%. The 3-year compound annual growth rate (CAGR) favors IR at 9.7% vs ROP's -7.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -2.8% | -18.5% | -20.7% | +20.4% | +4.5% |
| 1-Year ReturnPast 12 months | -0.4% | -38.0% | -43.0% | +20.9% | +7.8% |
| 3-Year ReturnCumulative with dividends | +31.9% | -21.0% | -14.5% | +5.9% | +28.6% |
| 5-Year ReturnCumulative with dividends | +54.1% | -17.5% | +1.8% | +0.7% | +27.9% |
| 10-Year ReturnCumulative with dividends | +299.5% | +115.0% | +137.1% | +189.3% | +720.9% |
| CAGR (3Y)Annualised 3-year return | +9.7% | -7.6% | -5.1% | +1.9% | +8.7% |
Risk & Volatility
Evenly matched — VRSK and IEX each lead in 1 of 2 comparable metrics.
Risk & Volatility
VRSK is the less volatile stock with a -0.04 beta — it tends to amplify market swings less than IR's 1.48 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IEX currently trades 96.0% from its 52-week high vs VRSK's 54.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.48x | 0.43x | -0.04x | 0.95x | 0.61x |
| 52-Week HighHighest price in past year | $100.96 | $584.03 | $322.92 | $223.84 | $626.28 |
| 52-Week LowLowest price in past year | $72.45 | $313.86 | $161.70 | $157.25 | $501.08 |
| % of 52W HighCurrent price vs 52-week peak | +76.8% | +60.3% | +54.1% | +96.0% | +93.9% |
| RSI (14)Momentum oscillator 0–100 | 43.3 | 43.6 | 39.5 | 67.6 | 54.6 |
| Avg Volume (50D)Average daily shares traded | 3.1M | 1.2M | 1.9M | 713K | 520K |
Analyst Outlook
IEX leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: IR as "Buy", ROP as "Buy", VRSK as "Hold", IEX as "Hold", MSCI as "Buy". Consensus price targets imply 32.4% upside for VRSK (target: $231) vs 12.7% for IEX (target: $242). For income investors, IEX offers the higher dividend yield at 1.31% vs IR's 0.10%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | $99.50 | $457.64 | $231.25 | $242.14 | $674.33 |
| # AnalystsCovering analysts | 15 | 23 | 25 | 29 | 27 |
| Dividend YieldAnnual dividend ÷ price | +0.1% | +0.9% | +1.0% | +1.3% | +1.2% |
| Dividend StreakConsecutive years of raises | 0 | 12 | 7 | 23 | 11 |
| Dividend / ShareAnnual DPS | $0.08 | $3.29 | $1.81 | $2.82 | $7.20 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.4% | +1.4% | +2.7% | +1.6% | +5.8% |
MSCI leads in 1 of 6 categories (Income & Cash Flow). ROP leads in 1 (Valuation Metrics). 2 tied.
IR vs ROP vs VRSK vs IEX vs MSCI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is IR or ROP or VRSK or IEX or MSCI a better buy right now?
For growth investors, Roper Technologies, Inc.
(ROP) is the stronger pick with 12. 3% revenue growth year-over-year, versus 5. 7% for Ingersoll Rand Inc. (IR). Roper Technologies, Inc. (ROP) offers the better valuation at 24. 8x trailing P/E (16. 1x forward), making it the more compelling value choice. Analysts rate Ingersoll Rand Inc. (IR) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IR or ROP or VRSK or IEX or MSCI?
On trailing P/E, Roper Technologies, Inc.
(ROP) is the cheapest at 24. 8x versus Ingersoll Rand Inc. at 53. 4x. On forward P/E, Roper Technologies, Inc. is actually cheaper at 16. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Roper Technologies, Inc. wins at 1. 68x versus IDEX Corporation's 4. 77x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — IR or ROP or VRSK or IEX or MSCI?
Over the past 5 years, Ingersoll Rand Inc.
(IR) delivered a total return of +54. 1%, compared to -17. 5% for Roper Technologies, Inc. (ROP). Over 10 years, the gap is even starker: MSCI returned +720. 9% versus ROP's +115. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IR or ROP or VRSK or IEX or MSCI?
By beta (market sensitivity over 5 years), Verisk Analytics, Inc.
(VRSK) is the lower-risk stock at -0. 04β versus Ingersoll Rand Inc. 's 1. 48β — meaning IR is approximately -4236% more volatile than VRSK relative to the S&P 500. On balance sheet safety, IDEX Corporation (IEX) carries a lower debt/equity ratio of 45% versus 16% for Verisk Analytics, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — IR or ROP or VRSK or IEX or MSCI?
By revenue growth (latest reported year), Roper Technologies, Inc.
(ROP) is pulling ahead at 12. 3% versus 5. 7% for Ingersoll Rand Inc. (IR). On earnings-per-share growth, the picture is similar: MSCI Inc. grew EPS 10. 7% year-over-year, compared to -29. 6% for Ingersoll Rand Inc.. Over a 3-year CAGR, ROP leads at 13. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IR or ROP or VRSK or IEX or MSCI?
MSCI Inc.
(MSCI) is the more profitable company, earning 38. 4% net margin versus 7. 6% for Ingersoll Rand Inc. — meaning it keeps 38. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MSCI leads at 54. 7% versus 18. 5% for IR. At the gross margin level — before operating expenses — MSCI leads at 82. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IR or ROP or VRSK or IEX or MSCI more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Roper Technologies, Inc. (ROP) is the more undervalued stock at a PEG of 1. 68x versus IDEX Corporation's 4. 77x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Roper Technologies, Inc. (ROP) trades at 16. 1x forward P/E versus 30. 0x for MSCI Inc. — 13. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for VRSK: 32. 4% to $231. 25.
08Which pays a better dividend — IR or ROP or VRSK or IEX or MSCI?
All stocks in this comparison pay dividends.
IDEX Corporation (IEX) offers the highest yield at 1. 3%, versus 0. 1% for Ingersoll Rand Inc. (IR).
09Is IR or ROP or VRSK or IEX or MSCI better for a retirement portfolio?
For long-horizon retirement investors, Verisk Analytics, Inc.
(VRSK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 04), 1. 0% yield, +137. 1% 10Y return). Both have compounded well over 10 years (VRSK: +137. 1%, IR: +299. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IR and ROP and VRSK and IEX and MSCI?
These companies operate in different sectors (IR (Industrials) and ROP (Industrials) and VRSK (Industrials) and IEX (Industrials) and MSCI (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
ROP, VRSK, IEX, MSCI pay a dividend while IR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.